| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.0B | $5.5B | $4.6B | $3.6B | $4.0B | $3.8B | $4.0B | $3.4B |
| Cost of Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.5B | $0.5B | $0.1B | $-0.5B | $0.2B | $0.2B | $0.0B | $-0.1B |
| EPS (Basic) | $9.77 | $8.45 | $1.74 | $-9.26 | $4.48 | $3.01 | $0.57 | $-1.48 |
| EPS (Diluted) | $9.77 | $8.45 | $1.74 | $-9.26 | $4.48 | $3.01 | $0.57 | $-1.48 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.6B | $8.3B | $7.1B | $6.5B | $6.8B | $6.3B | $5.9B | $5.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.3B | $0.7B | $0.6B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B |
| Total Liabilities | $7.1B | $6.4B | $5.6B | $5.0B | $4.6B | $4.3B | $4.1B | $3.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $1.0B | $0.5B | $0.4B | $0.5B | $0.6B | $0.5B | $0.4B |
| Investing Cash Flow | $-0.4B | $-0.8B | $-0.3B | $-0.3B | $-0.4B | $-0.4B | $-0.4B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.1B | $-0.1B | $0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.1B |